Expression Level of lncRNA CYTOR in Iranian Cervical Cancer Patients
- PMID: 37724154
- PMCID: PMC10505465
- DOI: 10.52547/rbmb.12.1.120
Expression Level of lncRNA CYTOR in Iranian Cervical Cancer Patients
Abstract
Background: A critical role has been known for lncRNAs in the initiation and development of cancers. Therefore, lncRNAs have been reported as the possible biomarkers in relation to the diagnosis and therapy of malignancies. This project examined the change in CYTOR lncRNA expression in human cervical cancer samples as compared with adjacent healthy ones.
Methods: We provided one hundred fifteen pairs of tumorous and adjacent healthy tissue specimens of cervical cancer patients. RNAs were isolated from tissue specimens and cDNAs were synthesized. We considered quantitative Real-time PCR (qRT-PCR) to examine the expression levels of CYTOR lncRNA. In addition, the biomarker activity of CYTOR and the associations between the lncRNA and clinicopathological characteristics were evaluated.
Results: The significant increased expression of CYTOR was obtained in cancerous samples as compared with non-cancerous ones (P< 0.0001). A significant correlation was indicated between CYTOR expression and the squamous subtype of cervical cancer (p=0.046). The receiver operating characteristic (ROC) curve-related AUC (area under the curve), specificity, and sensitivity were calculated 0.88, 81.74%, and 80%, respectively, which may introduce CYTOR as a potential biomarker.
Conclusion: CYTOR may be an effective oncogene and biomarker in cervical cancer cases given its increased expression in human cervical cancer tissues.
Keywords: Biomarker; CYTOR; Cervical cancer; lncRNA; qRT-PCR.
Conflict of interest statement
None.
Figures
Similar articles
-
Circulating CYTOR as a Potential Biomarker in Breast Cancer.Int J Mol Cell Med. 2020 Winter;9(1):83-90. doi: 10.22088/IJMCM.BUMS.9.1.83. Int J Mol Cell Med. 2020. PMID: 32832487 Free PMC article.
-
Alterations in the expression levels of long intergenic non-coding RNA APOC1P1-3 in cervical cancer tissue samples.Nucleosides Nucleotides Nucleic Acids. 2023;42(6):495-505. doi: 10.1080/15257770.2022.2160459. Epub 2022 Dec 23. Nucleosides Nucleotides Nucleic Acids. 2023. PMID: 36564178
-
Integrated analysis of two-lncRNA signature as a potential prognostic biomarker in cervical cancer: a study based on public database.PeerJ. 2019 Apr 22;7:e6761. doi: 10.7717/peerj.6761. eCollection 2019. PeerJ. 2019. PMID: 31065456 Free PMC article.
-
lncRNA cytoskeleton regulator RNA (CYTOR): Diverse functions in metabolism, inflammation and tumorigenesis, and potential applications in precision oncology.Genes Dis. 2021 Oct 23;10(2):415-429. doi: 10.1016/j.gendis.2021.08.012. eCollection 2023 Mar. Genes Dis. 2021. PMID: 37223495 Free PMC article. Review.
-
Long noncoding RNA CYTOR in cancer: A TCGA data review.Clin Chim Acta. 2018 Aug;483:227-233. doi: 10.1016/j.cca.2018.05.010. Epub 2018 May 8. Clin Chim Acta. 2018. PMID: 29750962 Review.
Cited by
-
Circulating Levels of HOTAIR- lncRNA Are Associated with Disease Progression and Clinical Parameters in Type 2 Diabetes Patients.Rep Biochem Mol Biol. 2023 Oct;12(3):448-457. doi: 10.61186/rbmb.12.3.448. Rep Biochem Mol Biol. 2023. PMID: 38618258 Free PMC article.
-
Association of Circulating Circular RNAs (hg38_circ_0008980, and CircDLGAP4) in Diagnosis, Diseases Severity, and Prognosis of Ischemic Stroke.Rep Biochem Mol Biol. 2023 Oct;12(3):476-486. doi: 10.61186/rbmb.12.3.476. Rep Biochem Mol Biol. 2023. PMID: 38618264 Free PMC article.
-
Upregulation of PCAT1, PCAT2, and PCAT3 LncRNAs in cervical cancer patients and their diagnostic value.BMC Res Notes. 2025 Jul 25;18(1):326. doi: 10.1186/s13104-025-07401-1. BMC Res Notes. 2025. PMID: 40713711 Free PMC article.
References
-
- Lagana AS, Garzon S, Raffaelli R, Ban Frangez H, Lukanovic D, Franchi M. Vaginal Stenosis After Cervical Cancer Treatments: Challenges for Reconstructive Surgery. J Invest Surg. 2021;34(7):754–5. - PubMed
-
- Cohen PA, Jhingran A, Oaknin A, Denny L. Cervical cancer. Lancet. 2019;393(10167):169–82. - PubMed
LinkOut - more resources
Full Text Sources